Elisa Agostinetto, MD, Jules Bordet Institute, Brussels, Belgium, highlights key considerations for young patients with breast cancer, particularly focusing on fertility preservation and family planning. Recent findings demonstrate the safety of assisted reproductive techniques (ART) for young women with germline breast cancer gene (BRCA) mutations and early breast cancer. These results offer hope for young patients desiring to start a family post-treatment, though prospective validation is needed. This interview took place at the 2024 European Society for Medical Oncology (ESMO) Breast Cancer Annual Congress in Berlin, Germany.
